פריוויג'ן

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

IMMUNOGLOBULINS, NORMAL HUMAN

MAH:

CSL BEHRING LTD., ISRAEL

ATC_code:

J06BA02

pharmaceutical_form:

תמיסה לאינפוזיה

composition:

IMMUNOGLOBULINS, NORMAL HUMAN 100 G/L

administration_route:

תוך-ורידי

prescription_type:

מרשם נדרש

manufactured_by:

CSL BEHRING AG, SWITZERLAND

therapeutic_group:

IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.

therapeutic_area:

IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.

therapeutic_indication:

1. Replacement therapy in- Primary immunodeficiency syndromes such as:- Congenital agammaglobulinaemia and hypogammaglobulinaemia- Common variable immunodeficiency- Severe combined immunodeficiency- Wiskott-Aldrich syndrome- Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections-Children with congenital AIDS and recurrent infections2. Immunomodulation- Immune thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgical interventions to correct the platelet count-Guillain-Barr? syndrome- Kawasaki disease3. Allogeneic bone marrow transplantation

authorization_date:

2016-06-30